Exact Mass: 390.17910079999996
Exact Mass Matches: 390.17910079999996
Found 500 metabolites which its exact mass value is equals to given mass value 390.17910079999996,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Meclizine
C25H27ClN2 (390.18626520000004)
Meclizine is only found in individuals that have used or taken this drug. It is a histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness. [PubChem]Along with its actions as an antagonist at H1-receptors, meclizine also possesses anticholinergic, central nervous system depressant, and local anesthetic effects. Meclizine depresses labyrinth excitability and vestibular stimulation and may affect the medullary chemoreceptor trigger zone. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3084 D002491 - Central Nervous System Agents D018926 - Anti-Allergic Agents
Compound II(R/S)
C21H27ClN2O3 (390.17101020000007)
L-Ala-Gamma-D-Glu-Meso-Diaminopimelic Acid
Fluocortin
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(R)-Hispaglabridin B
(R)-Hispaglabridin B is found in herbs and spices. (R)-Hispaglabridin B is isolated from Glycyrrhiza glabra (licorice). Isolated from Glycyrrhiza glabra (licorice). (R)-Hispaglabridin B is found in tea and herbs and spices.
Shinflavanone
Shinflavanone is found in herbs and spices. Shinflavanone is a constituent of Glycyrrhiza glabra (licorice). Constituent of Glycyrrhiza glabra (licorice). Shinflavanone is found in tea and herbs and spices.
Tryptophyl-Tryptophan
Tryptophyl-Tryptophan is a dipeptied compoosed of two tryptophan residues. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
11-Dehydrodexamethasone
Fluocortin
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Serylvalylglycylglutamic acid
Production by Alternaria alternata on Helianthus annuus (sunflower). Serylvalylglycylglutamic acid is found in fats and oils.
Corylinin
Corylifol A is a natural product found in Aspergillus flocculosus and Cullen corylifolium with data available. Corylifol A inhibits IL-6-induced STAT3 activation and phosphorylation, with an IC50 of 0.81 μM. Corylifol A inhibits IL-6-induced STAT3 activation and phosphorylation, with an IC50 of 0.81 μM.
Licoflavone B
Licoflavone B is a member of flavones. Licoflavone B is a natural product found in Lupinus albus, Glycyrrhiza glabra, and Glycyrrhiza inflata with data available. See also: Glycyrrhiza inflata root (part of). Licoflavone B is a flavonoid isolated from Glycyrrhiza inflata, inhibits S. mansoni ATPase (IC50, 23.78 μM) and ADPase (IC50, 31.50 μM) activity. Anti-schistosomiasis activity[1]. Licoflavone B is a flavonoid isolated from Glycyrrhiza inflata, inhibits S. mansoni ATPase (IC50, 23.78 μM) and ADPase (IC50, 31.50 μM) activity. Anti-schistosomiasis activity[1].
Yocon
A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine (has active moiety). Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
Rubranine
Euchrenone a5
Fulvinervin A
5-hydroxy-6-(4-hydroxycinnamoyl)-2-methyl-2-(4-methyl-3-pentenyl)-2h -1-benzopyran
Folinin
Paratocarpin C
Folitenol
lespeol
2,4-dihydroxy-4,5-[2-methyl-2-(4-methylpent-3-enyl)pyran]chalcone|isolespeol
(2S)-7,8-dihydro-5-hydroxy-2-methyl-2-(4-methyl-3-pentenyl)-8-phenyl-2H,6H-benzo[1,2-b:5,4-b]dipyran-6-one
2-O-Acetyl-6-O-(2-methylbutanoyl)-1-O-(2-methylpropanoyl)-beta-D-glucopyranose
(-)-(3R,7R)-9,10-dihydro-11xi-hydroxyjasmonic acid O(11)-beta-D-glucopyranoside
(-)-6-(3,3-dimethylallyl)-7-hydroxy-6,6-dimethylchromeno-(4,3,2,3)-flavanone|dinklagin A
1L-Myo-inositol 1beta-acetate 2alpha-methylbutanoate 3alpha-methylbutanoate 1(axial),4beta,5alpha,6beta
(acetoxymethyl-methylene-oxo-[?]yl)methyl 2-methylpropanoate
(3R*,7R*,8S*)-3-Acetoxy-15-(2-methyl)propanoyloxy-14-oxomelampa-1(10),4,11(13)-trien-8,12-olide
15-acetoxy-1alpha-<4-hydroxymethacryloyloxy>-arbusculin B
Val Ala Ser Asp
Rauwolscine HCl
C21H27ClN2O3 (390.17101020000007)
Rauwolscine hydrochloride is a potent and specific α2 adrenergic receptor antagonist with a Ki of 12 nM. Rauwolscine hydrochloride is a potent and specific α2 adrenergic receptor antagonist with a Ki of 12 nM.
Yocon
C21H27ClN2O3 (390.17101020000007)
A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine (has active moiety). Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
3-[3-[(2E)-3,7-dimethylocta-2,6-dienyl]-4-hydroxyphenyl]-7-hydroxychromen-4-one
7-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)chromen-4-one
C21H26O7_(2E,4E)-6-{[(5R,9aS,9bS)-9b-Hydroxy-6,6,9a-trimethyl-1-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-5-yl]oxy}-6-oxo-2,4-hexadienoic acid
3-[3-[(2E)-3,7-dimethylocta-2,6-dienyl]-4-hydroxyphenyl]-7-hydroxychromen-4-one
7-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)chromen-4-one [IIN-based on: CCMSLIB00000848794]
7-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)chromen-4-one [IIN-based: Match]
3-[3-[(2E)-3,7-dimethylocta-2,6-dienyl]-4-hydroxyphenyl]-7-hydroxychromen-4-one [IIN-based on: CCMSLIB00000846120]
3-[3-[(2E)-3,7-dimethylocta-2,6-dienyl]-4-hydroxyphenyl]-7-hydroxychromen-4-one [IIN-based: Match]
Ala Ala Glu Thr
Ala Ala Thr Glu
Ala Asp Ser Val
Ala Asp Val Ser
Ala Glu Ala Thr
Ala Glu Thr Ala
Ala Phe Gly Pro
C19H26N4O5 (390.19031060000003)
Ala Phe Pro Gly
C19H26N4O5 (390.19031060000003)
Ala Gly Phe Pro
C19H26N4O5 (390.19031060000003)
Ala Gly Pro Phe
C19H26N4O5 (390.19031060000003)
Ala Pro Phe Gly
C19H26N4O5 (390.19031060000003)
Ala Pro Gly Phe
C19H26N4O5 (390.19031060000003)
Ala Ser Asp Val
Ala Ser Val Asp
Ala Thr Ala Glu
Ala Thr Glu Ala
Ala Val Asp Ser
Ala Val Ser Asp
Asp Ala Ser Val
Asp Ala Val Ser
Asp Gly Ile Ser
Asp Gly Leu Ser
Asp Gly Ser Ile
Asp Gly Ser Leu
Asp Gly Thr Val
Asp Gly Val Thr
Asp Ile Gly Ser
Asp Ile Ser Gly
Asp Leu Gly Ser
Asp Leu Ser Gly
Asp Ser Ala Val
Asp Ser Gly Ile
Asp Ser Gly Leu
Asp Ser Ile Gly
Asp Ser Leu Gly
Asp Ser Val Ala
Asp Thr Gly Val
Asp Thr Val Gly
Asp Val Ala Ser
Asp Val Gly Thr
Asp Val Ser Ala
Asp Val Thr Gly
Glu Ala Ala Thr
Glu Ala Thr Ala
Glu Gly Ser Val
Glu Gly Val Ser
Glu Ser Gly Val
Glu Ser Val Gly
Glu Thr Ala Ala
Glu Val Gly Ser
Glu Val Ser Gly
Phe Ala Gly Pro
C19H26N4O5 (390.19031060000003)
Phe Ala Pro Gly
C19H26N4O5 (390.19031060000003)
Phe Gly Ala Pro
C19H26N4O5 (390.19031060000003)
Phe Gly Pro Ala
C19H26N4O5 (390.19031060000003)
Phe Pro Ala Gly
C19H26N4O5 (390.19031060000003)
Phe Pro Gly Ala
C19H26N4O5 (390.19031060000003)
Gly Ala Phe Pro
C19H26N4O5 (390.19031060000003)
Gly Ala Pro Phe
C19H26N4O5 (390.19031060000003)
Gly Asp Ile Ser
Gly Asp Leu Ser
Gly Asp Ser Ile
Gly Asp Ser Leu
Gly Asp Thr Val
Gly Asp Val Thr
Gly Glu Ser Val
Gly Glu Val Ser
Gly Phe Ala Pro
C19H26N4O5 (390.19031060000003)
Gly Phe Pro Ala
C19H26N4O5 (390.19031060000003)
Gly Ile Asp Ser
Gly Ile Ser Asp
Gly Leu Asp Ser
Gly Leu Ser Asp
Gly Pro Ala Phe
C19H26N4O5 (390.19031060000003)
Gly Pro Phe Ala
C19H26N4O5 (390.19031060000003)
Gly Ser Asp Ile
Gly Ser Asp Leu
Gly Ser Glu Val
Gly Ser Ile Asp
Gly Ser Leu Asp
Gly Ser Val Glu
Gly Thr Asp Val
Gly Thr Val Asp
Gly Val Asp Thr
Gly Val Glu Ser
Gly Val Ser Glu
Gly Val Thr Asp
Ile Asp Gly Ser
Ile Asp Ser Gly
Ile Gly Asp Ser
Ile Gly Ser Asp
Ile Ser Asp Gly
Ile Ser Gly Asp
Leu Asp Gly Ser
Leu Asp Ser Gly
Leu Gly Asp Ser
Leu Gly Ser Asp
Leu Ser Asp Gly
Leu Ser Gly Asp
Pro Ala Phe Gly
C19H26N4O5 (390.19031060000003)
Pro Ala Gly Phe
C19H26N4O5 (390.19031060000003)
Pro Phe Ala Gly
C19H26N4O5 (390.19031060000003)
Pro Phe Gly Ala
C19H26N4O5 (390.19031060000003)
Pro Gly Ala Phe
C19H26N4O5 (390.19031060000003)
Pro Gly Phe Ala
C19H26N4O5 (390.19031060000003)
Pro Ser Ser Thr
Pro Ser Thr Ser
Pro Thr Ser Ser
Ser Ala Asp Val
Ser Ala Val Asp
Ser Asp Ala Val
Ser Asp Gly Ile
Ser Asp Gly Leu
Ser Asp Ile Gly
Ser Asp Leu Gly
Ser Asp Val Ala
Ser Glu Gly Val
Ser Glu Val Gly
Ser Gly Asp Ile
Ser Gly Asp Leu
Ser Gly Glu Val
Ser Gly Ile Asp
Ser Gly Leu Asp
Ser Gly Val Glu
Ser Ile Asp Gly
Ser Ile Gly Asp
Ser Leu Asp Gly
Ser Leu Gly Asp
Ser Pro Ser Thr
Ser Pro Thr Ser
Ser Ser Pro Thr
Ser Ser Thr Pro
Ser Thr Pro Ser
Ser Thr Ser Pro
Ser Val Ala Asp
Ser Val Asp Ala
Ser Val Glu Gly
Ser Val Gly Glu
Thr Ala Ala Glu
Thr Ala Glu Ala
Thr Asp Gly Val
Thr Asp Val Gly
Thr Glu Ala Ala
Thr Gly Asp Val
Thr Gly Val Asp
Thr Pro Ser Ser
Thr Ser Pro Ser
Thr Ser Ser Pro
Thr Val Asp Gly
Thr Val Gly Asp
Val Ala Asp Ser
Val Asp Ala Ser
Val Asp Gly Thr
Val Asp Ser Ala
Val Asp Thr Gly
Val Glu Gly Ser
Val Glu Ser Gly
Val Gly Asp Thr
Val Gly Glu Ser
Val Gly Ser Glu
Val Gly Thr Asp
Val Ser Ala Asp
Val Ser Asp Ala
Val Ser Glu Gly
Val Ser Gly Glu
Val Thr Asp Gly
Val Thr Gly Asp
(-)-11-hydroxy-9,10-dihydrojasmonic acid 11-beta-D-glucoside
A monosaccharide derivative that is (-)-11-hydroxy-9,10-dihydrojasmonic acid attached to a beta-D-glucopyranosyl residue at position 11 via a glycosidic linkage.
TRP-TRP
A dipeptide formed from two L-tryptophan residues.
5-{4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethyl]oxan-2-yl}-3-methoxybenzene-1,2-diol
Fluprednidene
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XB - Corticosteroids, moderately potent, other combinations D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium
methyl (1S,15R,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate,hydrochloride
C21H27ClN2O3 (390.17101020000007)
11β,17α-dihydroxy-9α-fluoro-16α-methyl-3,20-dioxo-1,4-pregnadien-21-al
(2-hydroxy-2-methylpropyl) 4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxylate
C19H26N4O5 (390.19031060000003)
(3AS,6AS)-2-((BENZYLOXY)CARBONYL)-5-(TERT-BUTOXYCARBONYL)OCTAHYDROPYRROLO[3,4-C]PYRROLE-3A-CARBOXYLIC ACID
2,3-bis(n-hexylthio)-1,4-naphthalenedione
C22H30O2S2 (390.16871199999997)
3-[5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONAMIDO]-2,2,5,5-TETRAMETHYL-1-PYRROLIDINYLOXY
C20H28N3O3S (390.18512780000003)
2-[2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]acetic acid
C21H24F2N2O3 (390.17548980000004)
[9,9-bis(4-methylphenyl)fluoren-2-yl]boronic acid
C27H23BO2 (390.17910079999996)
4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2,6-dimethoxyphenol
1-N,6-N-bis(5-methyl-1H-pyrazole-3-carbonyl)hexanedihydrazide
5-(7-(6-Chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole
C21H27ClN2O3 (390.17101020000007)
Yohimbine hydrochloride
C21H27ClN2O3 (390.17101020000007)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
(-)-5-Methoxyisolariciresinol
A lignan that is 5,6,7,8-tetrahydronaphthalen-2-ol substituted by two hydroxymethyl groups at positions 6 and 7, a methoxy group at position 3 and a 4-hydroxy-3,5-dimethoxyphenyl group at position 8. It has been isolated from the stems of Sinocalamus affinis.
3-[(3,4-dimethoxyphenyl)methyl]-4-hydroxy-2-[(4-hydroxy-3-methoxyphenyl)methyl]butanoic acid
(2S)-2-azaniumyl-5-[[(2R)-1-(carboxylatomethylamino)-3-hexylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoate
C16H28N3O6S- (390.16987280000006)
Ala-Val-Asp-Ser
A tetrapeptide composed of L-alanine, L-valine, L-aspartic acid, and L-serine joined in sequence by peptide linkages.
2-[[4-Cyano-6,6,7-trimethyl-1-(4-morpholinyl)-5,8-dihydro-2,7-naphthyridin-3-yl]thio]acetic acid methyl ester
L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid
1-[2-(3,4-dimethoxyphenyl)ethyl]-6-propyl-2-sulfanylidene-7,8-dihydro-5H-pyrimido[4,5-d]pyrimidin-4-one
N-(2-furanylmethyl)-3-[3-[(4-methoxyphenyl)methyl]-2-imidazo[4,5-b]pyridinyl]propanamide
(4-Methylphenyl)-[4-[4-nitro-2-(1-pyrrolyl)phenyl]-1-piperazinyl]methanone
5-Methoxy-8-(2-hydroxy-3-buthoxy-3-methylbutyloxy)psoralen
A member of the class of psoralens that is psoralen substituted by a methoxy group at position 4 and a [(2R)-3-butoxy-2-hydroxy-3-methylbutyl]oxy group at position 9. Isolated from the roots of Angelica dahurica, it exhibits inhibitory activity against COX-2 and 5-lipooxygenase.
(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(2S,3R,4S)-3-[4-(cyclohexen-1-yl)phenyl]-1-(3-fluorobenzoyl)-4-(hydroxymethyl)azetidine-2-carbonitrile
C24H23FN2O2 (390.17434699999995)
(2S,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
3-[(2E)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-4-methyl-2-(2-phenylhydrazinylidene)-2H-pyrrol-3-yl]propanoic acid
methyl (3aR,4R,5R,6E,10E,11aR)-5-hydroxy-10-methyl-4-[(Z)-2-methylbut-2-enoyl]oxy-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
1,1,2,2-Tetrakis(trimethylsilyl)-1,2-disilacyclopentane
C15H42Si6 (390.19020120000005)
meclizine
C25H27ClN2 (390.18626520000004)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents D018926 - Anti-Allergic Agents
5-[7-[2-Chloro-4-(4-methyl-4,5-dihydrooxazol-2-yl)phenoxy]heptyl]-3-methyl-isoxazole
C21H27ClN2O3 (390.17101020000007)
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol
(+)-5-methoxylariciresinol
A lignan that is (+)-lariciresinol substituted by a methoxy group at position 5. It has been isolated from the stems of Sinocalamus affinis.
PF-4708671
PF-4708671 is a potent cell-permeable S6K1 inhibitor with a Ki of 20 nM and IC50 of 160 nM.
CorylifolA
CorylifolA is a natural compound that belongs to the class of flavonoids, which are widely distributed in plants and are known for their diverse biological activities. Specifically, CorylifolA is a type of isoflavone, a subclass of flavonoids. It has been identified in various plant species, including members of the Fabaceae family. The chemical structure of CorylifolA features a central ring structure composed of three carbon atoms and one oxygen atom, which is characteristic of all flavonoids. This core structure is decorated with hydroxyl groups and a variety of other functional groups that contribute to its specific properties and activities. Biologically, CorylifolA and other isoflavones have been the subject of significant research due to their potential health benefits. They are known to have antioxidant properties, which means they can help to neutralize harmful free radicals in the body and reduce oxidative stress. Additionally, isoflavones like CorylifolA are often studied for their potential anti-inflammatory, anti-cancer, and estrogenic or anti-estrogenic effects. In terms of pharmacological applications, CorylifolA and similar compounds are of interest for the development of therapeutic agents. However, it is important to note that the biological activities and potential uses of CorylifolA are still under investigation, and more research is needed to fully understand its effects and applications.
(1r,2r,5r,6r,7s,8s)-2,8-dihydroxy-1-methoxy-7-(7-methoxy-2h-1,3-benzodioxol-5-yl)-6-methyl-5-(prop-2-en-1-yl)bicyclo[3.2.1]octan-3-one
(3as,4r,5s,9s,9as,9bs)-5-(acetyloxy)-9-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(1s,2r,5s,6r,9r,10r)-8-formyl-6,10-dihydroxy-4,4-dimethyl-12-oxo-11-oxatetracyclo[7.3.1.0¹,⁹.0²,⁶]tridec-7-en-5-yl (2z)-hex-2-enoate
8-(acetyloxy)-2-(hexa-2,4-diyn-1-ylidene)-4-hydroxy-1,6-dioxaspiro[4.5]decan-3-yl 3-methylbutanoate
14-methoxy-3-methyl-9-methylidene-8-oxo-4,7,15-trioxatetracyclo[11.2.1.0³,⁵.0⁶,¹⁰]hexadec-13(16)-en-11-yl 2-methylbut-2-enoate
(1s,2r,4r,6s,8r,9z,11s)-8-(acetyloxy)-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-2-yl 2-methylprop-2-enoate
2-(hydroxymethyl)-1-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-2,12-dien-9-yl 2-methylbut-2-enoate
4-{hydroxy[(3s,4s)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl}-2,6-dimethoxyphenol
5-hydroxy-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)-2-phenyl-2h,3h-pyrano[3,2-g]chromen-4-one
methyl 11-hydroxy-4-[(2-methylbut-2-enoyl)oxy]-3,10-dimethylidene-2-oxo-3ah,4h,5h,8h,9h,11h,11ah-cyclodeca[b]furan-6-carboxylate
(3ar,4r,9r,11ar)-9-(acetyloxy)-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl (2z)-2-hydroxybut-2-enoate
1-{9-hydroxy-1,5,5-trimethyl-6,15-dioxatetracyclo[9.3.1.0⁴,¹³.0⁷,¹²]pentadeca-7,9,11-trien-8-yl}-3-phenylprop-2-en-1-one
[(1r,3s,7r,9r)-1-[(acetyloxy)methyl]-6-methylidene-5-oxo-4,12-dioxatricyclo[7.5.0.0³,⁷]tetradeca-10,13-dien-10-yl]methyl 2-methylpropanoate
(2e,4e)-5-[(1r,7s,8r,9r)-7-hydroxy-4-(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid
8-hydroxy-4'-methyl-6,9-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-3,2'-oxetan]-4-yl 2-(hydroxymethyl)prop-2-enoate
(3ar,4r,11ar)-10-[(acetyloxy)methyl]-6-formyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(2s,3r,4s,5s,6r)-2-[3-hydroxy-2-methyl-5-(2-phenylethyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2z,5z,9e)-2-[2-(2,5-dihydroxyphenyl)-2-oxoethylidene]-11-hydroxy-6-(hydroxymethyl)-10-methylundeca-5,9-dienoic acid
methyl (2s,4ar,6ar,10ar,10br)-2-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]-6a,10b-dimethyl-4-oxo-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
(2e)-1-[(2s)-5-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
(3s,4s)-3-hydroxy-4-methoxy-4-(7-methoxy-2-oxochromen-8-yl)-2-methylidenebutyl 3-methylbutanoate
(1r)-1-(5,7-dimethoxy-2-oxochromen-8-yl)-3-methyl-2-oxobutyl 3-methylbutanoate
10-[(acetyloxy)methyl]-6-formyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(2s)-5-hydroxy-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)-2-phenyl-2h,3h-pyrano[3,2-g]chromen-4-one
(4ar,5s,6r,6as,11as,11br)-4a,6-dihydroxy-4,4,11b-trimethyl-1,7-dioxo-2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
(1r,13r)-7,7-dimethyl-18-(3-methylbut-2-en-1-yl)-8,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-2,4(9),5,10,14(19),15,17-heptaen-17-ol
8-{8,8-dimethyl-2h,3h,4h-pyrano[3,2-g]chromen-3-yl}-2,2-dimethylchromen-5-ol
[5,8-dihydroxy-7-(2-hydroxypropyl)-1,4a-dimethyl-6,10-dioxo-2,3,4,10a-tetrahydrophenanthren-1-yl]methyl formate
6-({9b-hydroxy-6,6,9a-trimethyl-1-oxo-3h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl}oxy)-6-oxohexa-2,4-dienoic acid
(2s,11s)-17,17-dimethyl-6-(3-methylbut-2-en-1-yl)-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5(10),6,8,13,15,19-heptaen-7-ol
(3as,4r,5s,9r,9as,9bs)-5-(acetyloxy)-9-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
6-(1-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}pentyl)-4-methoxy-5,6-dihydropyran-2-one
(2s,11s)-17,17-dimethyl-8-(3-methylbut-2-en-1-yl)-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5(10),6,8,13,15,19-heptaen-7-ol
[(3ar,7s,11as)-7-(acetyloxy)-10-formyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-6-yl]methyl 2-methylpropanoate
methyl 6-(3-hydroxy-4,4-dimethyl-2,3-dihydro-1,5-benzodioxepin-7-yl)-2-(methoxymethylidene)-3-methyl-4-oxohex-5-enoate
2-[2-(3,4-dihydroxyphenyl)ethyl]tetrahydro-6-(3,4,5-trihydroxyphenyl)-2h-pyran-4-ol; (2s,4s,6s)-form,3',3''-di-me ether
{"Ingredient_id": "HBIN003642","Ingredient_name": "2-[2-(3,4-dihydroxyphenyl)ethyl]tetrahydro-6-(3,4,5-trihydroxyphenyl)-2h-pyran-4-ol; (2s,4s,6s)-form,3',3''-di-me ether","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "NA","Ingredient_weight": "390.43","OB_score": "NA","CAS_id": "182369-54-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8792","PubChem_id": "NA","DrugBank_id": "NA"}
(?)-5'-methoxyisolariciresinol
{"Ingredient_id": "HBIN011760","Ingredient_name": "(?)-5'-methoxyisolariciresinol","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)CC2COC(C2CO)C3=CC(=C(C=C3)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13969","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5'-methoxylariciresinol
{"Ingredient_id": "HBIN011764","Ingredient_name": "5'-methoxylariciresinol","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C2C(C(CO2)CC3=CC(=C(C=C3)O)OC)CO","Ingredient_weight": "390.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13979","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44559567","DrugBank_id": "NA"}
5-methoxy-trans-dihydrodehydrodiconiferylalcohol
{"Ingredient_id": "HBIN011778","Ingredient_name": "5-methoxy-trans-dihydrodehydrodiconiferylalcohol","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "COC1=CC(=CC2=C1OC(C2CO)C3=CC(=C(C(=C3)OC)O)OC)CCCO","Ingredient_weight": "390.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13900","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "56838440","DrugBank_id": "NA"}
altissimacouniarin G
{"Ingredient_id": "HBIN015783","Ingredient_name": "altissimacouniarin G","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "CC(=CC1CC(C(O1)COC2=C(C=C3C=CC(=O)OC3=C2OC)OC)(C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "34516","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-{4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl}-2,6-dimethoxyphenol
4-[3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2,6-dimethoxyphenol
(2z,3s,5e)-2-[2,2-bis(acetyloxy)ethylidene]-6,10-dimethyl-1-oxoundeca-5,9-dien-7-yn-3-yl acetate
(5s)-1-(3,4-dihydroxy-5-methoxyphenyl)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)heptan-3-one
2-formyl-7'-hydroxy-3-methyl-10'-methylidene-2',11'-dioxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-6-yl acetate
(2r,11r)-17,17-dimethyl-8-(3-methylbut-2-en-1-yl)-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5(10),6,8,13,15,19-heptaen-7-ol
{9-[(acetyloxy)methyl]-14-methylidene-13-oxo-6,12-dioxatricyclo[9.3.0.0⁵,⁷]tetradeca-3,8-dien-4-yl}methyl 2-methylpropanoate
(3s,3ar,4s,4's,6ar,8s,9ar,9bs)-8-hydroxy-4'-methyl-6,9-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-3,2'-oxetan]-4-yl 2-(hydroxymethyl)prop-2-enoate
6-(acetyloxy)-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,10h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylprop-2-enoate
2-{2-[(acetyloxy)methyl]oxiran-2-yl}-5-{[(2-methylpropanoyl)oxy]methyl}phenyl 2-methylbut-2-enoate
1-[7-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
2,8-dihydroxy-1-methoxy-7-(7-methoxy-2h-1,3-benzodioxol-5-yl)-6-methyl-5-(prop-2-en-1-yl)bicyclo[3.2.1]octan-3-one
[6,9,10-trihydroxy-1,4a-dimethyl-5,8-dioxo-7-(prop-2-en-1-yl)-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methyl formate
1-[5-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
(6s)-6-[(1s)-1-{[(2r,3s,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}pentyl]-4-methoxy-5,6-dihydropyran-2-one
3-{3-[(1z,3r)-3,7-dimethylocta-1,6-dien-1-yl]-4-hydroxyphenyl}-7-hydroxychromen-4-one
7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2,4(9),10,15(24),16,18(23),21-heptaene
3-(4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)-7-hydroxychromen-4-one
2-(2,2-dimethylchromen-6-yl)-7-hydroxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-(acetyloxy)-3,4,5-trihydroxy-6-[(2-methylbutanoyl)oxy]cyclohexyl 2-methylbutanoate
(2r,11r)-17,17-dimethyl-6-(3-methylbut-2-en-1-yl)-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5(10),6,8,13,15,19-heptaen-7-ol
1-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(2,2-dimethylchromen-6-yl)prop-2-en-1-one
(3as,4s,6s,10r,11ar)-6-(acetyloxy)-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,10h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylprop-2-enoate
(3ar,4r,7s,11s,11as)-7-ethoxy-6-formyl-11-hydroxy-3,10-dimethylidene-2-oxo-3ah,4h,7h,8h,9h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylprop-2-enoate
(3as,5ar,6s,9bs)-9-[(acetyloxy)methyl]-5a-methyl-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,8h,9bh-naphtho[1,2-b]furan-6-yl 2-(hydroxymethyl)prop-2-enoate
2-[(6ar,8r,9r,9as)-9-(acetyloxy)-2-oxo-6ah,8h,9h,9ah-furo[2,3-h]chromen-8-yl]propan-2-yl (2r)-2-methylbutanoate
8-{8,8-dimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-yl}-2,2-dimethylchromen-5-ol
(3s,3ar,4s,4'r,6ar,8s,9ar,9bs)-8-hydroxy-4'-methyl-6,9-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-3,2'-oxetan]-4-yl 2-(hydroxymethyl)prop-2-enoate
2-[9-(acetyloxy)-2-oxo-6ah,8h,9h,9ah-furo[2,3-h]chromen-8-yl]propan-2-yl 2-methylbutanoate
(1s,2r)-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1-{[(2z)-2-methylbut-2-enoyl]oxy}propan-2-yl (2z)-2-methylbut-2-enoate
3-heptyl-3,5,10-trihydroxy-7-methoxy-1h,4h-naphtho[2,3-c]pyran-8,9-dione
methyl (2s,4as,6s,6ar,9r,10as,10bs)-2-(furan-3-yl)-6,9-dihydroxy-6a,10b-dimethyl-4-oxo-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
7-ethoxy-6-formyl-11-hydroxy-3,10-dimethylidene-2-oxo-3ah,4h,7h,8h,9h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylprop-2-enoate
5-[(2s,4r,6s)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethyl]oxan-2-yl]-3-methoxybenzene-1,2-diol
(1r,2r)-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1-{[(2z)-2-methylbut-2-enoyl]oxy}propan-2-yl (2z)-2-methylbut-2-enoate
1-(3,4-dimethoxyphenyl)-2-[4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenoxy]propane-1,3-diol
2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,8-dihydroxy-6-methylanthracene-9,10-dione
1-(3,4-dihydroxy-5-methoxyphenyl)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)heptan-3-one
1-(2,4-dihydroxyphenyl)-3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]prop-2-en-1-one
2-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]phenyl (3s)-3-(acetyloxy)butanoate
(1s,6r,7r)-9-[(1z)-2-isopropyl-3-methoxy-3-oxoprop-1-en-1-yl]-5,5-dimethyl-8,11-dioxo-12-oxatricyclo[5.3.2.0¹,⁶]dodec-9-ene-10-carboxylic acid
(1s,3r,5r,6s,10r,11s,14s)-14-methoxy-3-methyl-9-methylidene-8-oxo-4,7,15-trioxatetracyclo[11.2.1.0³,⁵.0⁶,¹⁰]hexadec-13(16)-en-11-yl (2e)-2-methylbut-2-enoate
(1s,5s,6s,7r)-2,8-dihydroxy-1-methoxy-7-(7-methoxy-2h-1,3-benzodioxol-5-yl)-6-methyl-5-(prop-2-en-1-yl)bicyclo[3.2.1]octan-3-one
methyl 2-(furan-3-yl)-6,9-dihydroxy-6a,10b-dimethyl-4-oxo-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
2-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one
(2e)-1-[(1s,9s,12s)-3,5-dihydroxy-12-isopropyl-9-methyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-2,4,6,10-tetraen-6-yl]-3-phenylprop-2-en-1-one
(1s,13r)-7,7-dimethyl-18-(3-methylbut-2-en-1-yl)-8,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-2,4(9),5,10,14(19),15,17-heptaen-17-ol
3-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxyphenyl}-7-hydroxychromen-4-one
2-(3,7-dimethylocta-2,6-dien-1-yl)-1,8-dihydroxy-6-methylanthracene-9,10-dione
6,15-bis(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11,13,15-heptaene-5,14-diol
(2s)-2-(2,2-dimethylchromen-6-yl)-7-hydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
8-[(3r)-8,8-dimethyl-2h,3h,4h-pyrano[3,2-g]chromen-3-yl]-2,2-dimethylchromen-5-ol
(2r,11r)-16,16-dimethyl-6-(3-methylbut-2-en-1-yl)-4,12,15-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5(10),6,8,13,17,19-heptaen-7-ol
17,17-dimethyl-6-(3-methylbut-2-en-1-yl)-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5(10),6,8,13,15,19-heptaen-7-ol
(2e)-1-[(1r,4s,13r)-9-hydroxy-1,5,5-trimethyl-6,15-dioxatetracyclo[9.3.1.0⁴,¹³.0⁷,¹²]pentadeca-7,9,11-trien-10-yl]-3-phenylprop-2-en-1-one
(2r,10r)-17,17-dimethyl-5-(3-methylbut-2-en-1-yl)-3,12,16-trioxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),4(9),5,7,13,15(20),18-heptaen-6-ol
7-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-8-(3-methylbut-2-en-1-yl)chromen-4-one
8-[(3s)-8,8-dimethyl-2h,3h,4h-pyrano[3,2-g]chromen-3-yl]-2,2-dimethylchromen-5-ol
8-[(3r)-8,8-dimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-yl]-2,2-dimethylchromen-5-ol
(2r,3r,4s,5r,6r)-2-hydroxy-6-(hydroxymethyl)-4,5-bis[(2-methylpropanoyl)oxy]oxan-3-yl 2-methylpropanoate
4,5,10,11-tetramethoxy-16λ⁵-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1,3,5,7,9,11,13,15,20-nonaen-16-ylium
[C24H24NO4]+ (390.17052440000003)